TB-500 5 mg

TB-2026-001Lot QL5GDAnalyzed October 7, 2026

Timeline

Ordered

October 3, 2026

Received

October 5, 2026

Analyzed

October 7, 2026

Sample

Name

TB-500 5 mg

Expected

TB-500

Amount

1 vial, lyophilized powder

Testing

Client

Flatirons Research Co

Test type

Content & purity

Method

HPLC-UV

Content, how much is in it

4.97mg

Label claim: 5 mg

Purity, how clean it is

>99%

Peptide purity, HPLC-UV peak area

Chromatogram

HPLC-UV

12.44 min, TB-500, >99%

Analyst Comments

White lyophilized powder, copper-cap vial, received sealed.

Analyst Signature

Max Barrett

Lab Director, PuriLab Analytical

Analysis date: October 7, 2026

Verification Code

TB-3DSB-KRQA

Verify at purilab.org/verify/TB-3DSB-KRQA

Scan to Verify

TB-3DSB-KRQA

Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.

PuriLab Analytical|admin@purilab.org

Page 1 of 1